Lv1
10 积分 2025-03-17 加入
Effect of interleukin 23 inhibitors (risankizumab and guselkumab) on cardiovascular and cerebrovascular risk in psoriasis patients
16小时前
待确认
Impact of IL-23 inhibition versus methotrexate on select major fracture risk and progression to joint arthroplasty in psoriatic patients
22小时前
已完结
Impact of IL-23 inhibition versus methotrexate on select major fracture risk and progression to joint arthroplasty in psoriatic patients
23小时前
已关闭
Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy
15天前
已完结
Montmorillonite restricts free fatty acid liberation and alters self-assembled structures formed during in vitro lipid digestion
26天前
已完结
Clinical practice guidelines for acute infectious diarrhea in children in China (2024)
26天前
已完结
Myosin light chain kinase-mediated epithelial barrier dysfunction as a potential pathogenic mechanism of afatinib-induced diarrheas: A study in human colonoid model
26天前
已完结
Guselkumab-mediated marked improvement in a case of refractory ulcerative colitis resistant to mirikizumab: evidence for switching between IL-23p19 inhibitors
1个月前
已完结
Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: a nationwide cohort study
1个月前
已完结
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials
1个月前
已完结
皖公网安备34019202002308
